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Abstract
Objective To study the associations of objectively measured physical activity (PA) and sedentary time (ST) with the com-
bined outcome of incident stroke, myocardial infarction (MI) or all-cause mortality in older adults.
Methods N = 3343 men and women aged 70 who participated in a health survey between 2012 and 2017 were included. 
Actigraph GT3X+ accelerometers were used to measure light-intensity PA (LPA), moderate-intensity PA (MPA) and ST 
for 1 week. Incident cases of cardiovascular disease (CVD) in terms of stroke or MI, and all-cause mortality were identified 
using national registers. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using multivariable-adjusted 
Cox regressions.
Results During a mean follow-up of 2.7 years (0.1–5.6), there were 124 events of CVD or all-cause mortality. After adjusting 
for potential confounders and mediators, every 30-min/day increment in LPA was associated with 11% lower risk of CVD or 
all-cause mortality (HR 0.89, 95% CI 0.82–0.97), and every 30-min/day increment in MPA was associated with 36% lower 
risk (HR 0.64, 95% CI 0.48–0.84). Every 1-h/day increment in ST increased the risk of the outcomes by 33% (HR 1.33, 95% 
CI 1.14–1.56), although there was no significant association among participants who performed ≥ 30 min/day MPA (HR 
1.11, 95% CI 0.82–1.50, P = 0.034 for interaction). None of the associations were modified by sex (P > 0.4 for all).
Conclusion Objectively measured LPA and MPA are each associated with lower risk of stroke, MI or all-cause mortality in 
70-year-old individuals, while ST is associated with increased risk. The greatest risk reduction is observed for MPA, which 
also appears to attenuate some of the increased risks associated with ST.
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Key Points 
In this study of more than 3300 70-year-old men and 
women, we found that both light- and moderate-intensity 
physical activity were each linked to lower risk of stroke, 
myocardial infarction or all-cause mortality. Moderate-
intensity physical activity entailed the greatest relative 
risk reduction, around threefold that of light-intensity 
physical activity.
Sedentary behavior was linked to an increased risk of 
stroke, myocardial infarction or all-cause mortality. 
However, we also found that some of the increased risks 
pertaining to sedentary behavior may potentially be 
attenuated by performing moderate-intensity physical 
activity.
The findings from the present study may support the 
development and implementation of environmental 
actions and interventions aiming to reduce the risk of 
cardiovascular disease and premature death in older 
adults. Essentially, the main finding could be translated 
into one simple take-home message that is easily com-
municated to the public at large: “Regardless of intensity, 
the more you move and the less you sit, the better”.
1 Introduction
Cardiovascular disease (CVD) is strongly related to ageing 
[1, 2], and of all CVDs, stroke and myocardial infarction 
(MI) cause the majority of deaths [3]. Recently, these were 
also shown to increase in conjunction with the rapid popu-
lation ageing [4]. However, the World Health Organization 
states that at least 80% of all stroke and MI may be prevented 
through lifestyle changes [5]. Therefore, identifying key 
behavioral factors that could substantially reduce the risk of 
CVDs including stroke and MI in older people specifically 
is pivotal to effectively manage the rapid growth of the older 
population [4, 6], and would be of interest to healthcare pro-
viders, policymakers and stakeholders considering that CVD 
impose a significant economic burden for the society [7, 8].
An abundant and convincing body of evidence points to 
the vast importance of adopting an active lifestyle to attain 
health benefits all the way from a cellular to a disease-spe-
cific level [9, 10]. Specifically, the positive effects of physi-
cal activity (PA) and hazards of sedentary behavior in rela-
tion to the risk of incident CVD and mortality have been 
demonstrated by numerous studies during the recent years 
[11–15]. However, until more recently, most of the research 
was conducted using self-reported methods for assessing 
PA [16], which are more inaccurate compared to objective 
methods due to their susceptibility to recall- and social desir-
ability biases [17, 18]. In addition, they have limited ability 
to capture light-intensity PA (LPA) and sedentary time (ST) 
[19, 20], which is a particularly dilemma when studying 
older people given that most of the PA that they perform is 
LPA, and they spend at least 60–75% of their awake time in 
a sedentary state [21, 22].
Consequently, there has been a request for more studies 
investigating the association of objectively measured PA of 
different intensities and sedentary behavior with clinical 
health outcomes [16]. In particular, the association of LPA 
and ST with CVD and mortality in older people has gained 
increased attention; however, the findings are inconsistent 
[23–26]. This type of research has high clinical relevance 
given that there may be a misconception of the volume and 
intensity of PA that is necessary to reduce the risk of CVD 
which acts as a barrier towards PA [9, 10]. In the wake of 
the above, and the low adherence to the current PA rec-
ommendations [2], evidence for benefits pertaining to LPA 
may have a fundamental impact on PA promotion and would 
facilitate for older people to adopt and adhere to an active 
lifestyle. To this end, we investigated the associations of 
objectively measured PA of different intensities and ST, with 
the prospective risk of stroke, MI or all-cause mortality in a 
large cohort of 70-year-old men and women.
2  Methods
2.1  Study Design and Population
This was a prospective cohort study based on the ongoing 
population-based primary prevention study Healthy Age-
ing Initiative (HAI) conducted in Umeå, a municipality in 
northern Sweden with 128,901 inhabitants in 2019. HAI 
aims to identify traditional and novel risk factors for CVD, 
falls, and fractures among all 70-year-olds in Umeå. The par-
ticipants partake in an extensive health examination includ-
ing objective measurements of PA, body composition, and 
cardiometabolic risk markers among others. The participants 
are instructed to be in a fasting state for at least 4 h when 
arriving to the clinic. There, the examinations are performed 
by one of five research nurses supported by two chief physi-
cians (AN and PN). To be included, one must be a citizen 
of Umeå municipality and at the age of 70. Recruitment is 
performed using population registers, and there are no exclu-
sion criteria. Around 70% of all eligible individuals choose 
to participate in the HAI-study [27]. In the present study, all 
HAI-participants from May 2012–October 2017 with avail-
able measures of objective PA were eligible for inclusion. 
The HAI-study and the present study were both approved by 
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the Regional Ethical Review Board in Umeå, Sweden (no. 
07-031M with extensions).
2.2  Assessment of Physical Activity and Sedentary 
Time
PA and ST were measured during 1 week of registration 
using Actigraph GT3X+ accelerometers (Actigraph, Pen-
sacola, FL, USA). The accelerometer was attached to a hip-
worn belt and placed at the nondominant hip of the partici-
pants. The instructions were to wear the accelerometer for 
7 days at all times except for when sleeping, showering or 
bathing, and to be normally active during these days. The 
raw accelerometer data were collected at 30 Hz frequency 
and filtered using the standard Actigraph filter to eliminate 
non-human accelerations. Using Actilife software 6.11.3, 
the raw data were transformed into counts of movement in 
60 s epoch lengths. Next, wear time validation was applied, 
where participants were required to have accumulated ≥ 10 h 
wear time/day for ≥ 4 days to be included in the analysis. 
Non-wear time was defined as at least 60 consecutive min-
utes of zero counts, with an allowance of a maximum of 
2 min of counts between 0–100. Cut-points used for clas-
sification of PA intensities was based on the work by Freed-
son [28], classifying ST, LPA, moderate-intensity PA (MPA) 
and vigorous-intensity PA (VPA) as follows: ST < 100 
CPM; LPA (100–1951 CPM); MPA (1952–5724 CPM); 
VPA (≥ 5725 CPM). Moderate-to-vigorous PA (MVPA) 
was calculated by summing MPA and VPA. Because not 
all participants wore the accelerometer for the full week of 
registration, adherence to the PA recommendations [16] was 
calculated based on daily averages, where participants with 
at least 30 min/day of MVPA were considered to meet the 
PA recommendations.
2.3  Assessment of Other Variables and Covariates
Baseline data and selected covariates were collected in 
the HAI-study and through national registers. Specifically, 
height and weight were measured to calculate the body mass 
index (BMI, kg/m2). Blood pressure was measured using a 
digital automatic blood pressure device Omron M6 Com-
fort HEM-7221-E (Omron Healthcare, Kyoto, Japan) after a 
15-min rest. Fasting blood glucose was measured using the 
HemoCue 201 RT system (Radiometer Medical ApS, Den-
mark), while blood lipids were analyzed at the accredited 
laboratory at the department of clinical chemistry, Umeå 
University hospital. Whole-body scans using a Lunar iDXA 
device with the CoreScan application (GE Healthcare Lunar, 
Madison, WI, USA) were performed to quantify visceral 
adipose tissue. Socioeconomic data (education, marital sta-
tus, income) were collected from the registers of Statistics 
Sweden. Information on medications was collected from 
the Prescribed Drug Register, which covers all medications 
dispensed at pharmacies in Sweden since July 2005. Data 
on previously diagnosed medical conditions were collected 
from the National Patient Register (NPR), superintended 
by the Swedish National Board of Health and Welfare. The 
NPR covers all inpatient care in Sweden since 1987 and all 
secondary outpatient care since 2001.
2.4  Ascertainment of CVD and All‑Cause Mortality
The main outcome was the composite endpoint of CVD 
(stroke or MI) or all-cause mortality until 31 December 
2017. Secondarily, CVD and all-cause mortality were ana-
lyzed separately. Incident cases of stroke and MI were col-
lected from the NPR and using the International Classifica-
tion of Diseases, 10th ed diagnostic codes I61–I64 and I21. 
In general, the positive predictive value (PPV) for diagnoses 
in the NPR is between 85 and 95%, where the PPV for diag-
nosis of stroke is between 69 and 99% and for MI, the PPV 
is 86–100% [29–31]. Data on all-cause mortality were col-
lected using the Swedish Cause of Death Register which is 
complete since 1961 [32].
2.5  Data Linkage
All HAI-data and registry data were linked together using 
the personal identity number that is unique and issued to 
all residents of Sweden. The data files were retrieved from 
the National Board of Health and Welfare on December 21, 
2018.
2.6  Statistical Analysis
To examine the associations between the exposures and 
the outcomes, Cox proportional hazard regression models 
were performed. The proportional hazards assumption was 
assessed using covariate-by-time interaction terms, and the 
assumption was not violated. Hazard ratios (HR) and 95% 
confidence intervals (CI) were estimated for 30-min/day 
increments in LPA, MPA and MVPA, and for 1-h/day incre-
ments in ST. Follow-up time was calculated as the number 
of days from participation in HAI until the first incident 
case of either stroke, or MI, or death, whichever came first. 
Following the first event, participants were censored. If no 
event occurred, follow-up time ended on 31 December 2017. 
Linearity was tested by adding squared terms for each expo-
sure to the models. Adjustment for potential confounders 
and mediators was performed in multiple steps. Model 1 
was adjusted for sex and accelerometer wear time. Model 
2 was additionally adjusted for smoking (yes/no), marital 
status (married/never married/widowed/divorced), level of 
education (primary/secondary/post-secondary), and dispos-
able income. In model 3, CVD-history (MI/stroke/angina 
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pectoris) and medication (anti-hypertensives/anti-coag-
ulants/statins) was added. In the 4th and finally adjusted 
model, systolic blood pressure, visceral adipose tissue, fast-
ing blood glucose, and low-density lipoprotein cholesterol 
was added.
Next, using Cox regression models, the associations were 
investigated in subgroups according to significant risk fac-
tors for the composite endpoint of CVD or mortality iden-
tified in the main analyses. In addition, the associations 
of LPA and MPA with the composite endpoint were also 
investigated in subgroups of participants with ST < 8.8 h/
day and ≥ 8.8 h/day (median split), while the association of 
ST with the main outcome was investigated in subgroups 
based on amount of MPA (0–15 min/day, 16–29 min/day 
and ≥ 30 min/day). Interactions were tested by adding prod-
uct terms for each covariate and exposure and placing them 
into the Cox model. Each subgroup analysis was adjusted 
for sex, accelerometer wear time and other significant risk 
factors.
Finally, in an attempt to decrease the risk of reverse-cau-
sality bias, a sensitivity analysis was conducted. For each 
exposure, a Cox regression model was performed where all 
participants with a history of CVD were excluded, as were 
all participants with a follow-up time of 6 months or less. 
These models were adjusted according to model 4 in the 
main analysis, described two paragraphs above. SPSS ver-
sion 25.0 (IBM, Corp. Armonk, NY) was used to perform all 
analyses with the significance level set at P < 0.05.
3  Results
3.1  Participant Characteristics
From 3618 consecutive individuals that participated in HAI 
from May 2012 to October 2017, 275 (7.6%) had insuffi-
cient accelerometer wear time and were excluded from the 
analysis. Thus, in total 3343 participants (51% female) with 
a mean age of 70.5 years were included in this study. During 
1 week of registration, 1604 participants (48.0%) adhered to 
the PA recommendations of at least 30 min/day of MVPA. 
Mean daily wear time was 13.8 h and mean number of wear 
days was 6.6 days. Common diagnoses were depression 
(20.1%) and cancer (18.7%), while 3% and 4% had previ-
ously suffered a stroke and MI, respectively (Table 1).
3.2  Physical Activity and the Risk of CVD 
or Mortality
During a mean follow-up time of 2.7 years (0.1–5.6), there 
were 124 events of the composite endpoint CVD or mortal-
ity (stroke, 39; MI, 35; death, 50) with an incidence rate (IR) 
of 14.2 per 1000-person-years (PY). Addition of the squared 
Table 1  Baseline characteristics of the study cohort comprising 3343 
men and women aged 70 who participated in the Healthy Ageing Ini-
tiative study during May 2012–October 2017
BMI body mass index, LPA light-intensity physical activity, MPA 
moderate-intensity physical activity, MVPA moderate-to-vigorous 
physical activity, ST sedentary time, VPA vigorous-intensity physical 
activity
a Calculated based on daily averages. Participants with at least 30 min/
day of MVPA were considered to meet the recommendations
b Education and marital status recorded in the calendar year before the 
baseline date
c Prescriptions filled since July 2005
Age, years 70.5 ± 0.1
Female sex, n (%) 1693 (50.6)
Currently smoking, n (%) 199 (6.0)
BMI, kg/m2 26.4 ± 4.2
Visceral adipose tissue, g 1495 ± 972
Systolic blood pressure, mmHg 139 ± 17
Diastolic blood pressure, mmHg 81 ± 9
Fasting blood glucose, mmol/l 5.7 ± 1.2
Low-density lipoprotein cholesterol, mmol/ 3.3 ± 1.1
High-density lipoprotein cholesterol, mmol/l 1.6 ± 0.5
Total cholesterol, mmol/l 5.5 ± 1.2
Triglycerides, mmol/l 1.3 ± 0.7
Accelerometer measurements
 ST, h/day 8.9 ± 1.4
 LPA, min/day 263.6 ± 71.6
 MPA, min/day 32.5 ± 24.9
 VPA, min/day 0.9 ± 4.1
 MVPA, min/day 33.4 ± 25.7
 Adherence to PA recommendations, n (%)a 1604 (48.0)
 Wear time, h/day 13.8 ± 1.34
 Wear days, n 6.6 ± 1.0





 Missing data, n 4 (0.1)
Marital status,b n (%)
 Married 2219 (66.4)
 Never married 287 (8.6)
 Widowed 260 (7.8)
 Divorced 577 (17.3)
 Missing data, n 0
Diagnoses and medications,c n (%)
 Stroke 112 (3.4)
 Myocardial infarction 143 (4.3)
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term for each exposure did not indicate that the associa-
tions were nonlinear (P for nonlinearity > 0.50 for all). After 
adjusting for sex and accelerometer wear time, every 30-min/
day increment in LPA was associated with 13% lower risk of 
CVD or mortality (HR 0.87, 95% CI 0.80–0.95), and 11% 
lower risk in the finally adjusted model (HR 0.89, 95% CI 
0.82–0.97, Table 2). Furthermore, every 30-min/day incre-
ment in MPA was associated with 44% lower risk of CVD 
or mortality after adjusting for sex and wear time (HR 0.56, 
95% CI 0.43–0.74), which was reduced to 36% in the finally-
adjusted model (HR 0.64, 95% CI 0.49–0.83, Table 2). Other 
significant risk factors for the composite endpoint of CVD or 
mortality included sex, fasting blood glucose, annual dispos-
able income, smoking, anti-coagulant medication and statins 
(P < 0.05 for all). Based on the 95% CIs, the association 
between MPA and the composite endpoint was significantly 
stronger than the association between LPA and the compos-
ite endpoint in at least model 1 and model 2 (Table 2). The 
associations for the exposure MVPA were similar to those 
for MPA (Table 2).
Figures 1 and 2 present the results of the subgroup- and 
interaction analyses performed for LPA and MPA. Every 
30-min/day increment in MPA was more strongly associ-
ated with lower risk of CVD or mortality in participants 
with above median ST/day (HR 0.48, 95% CI 0.32–0.74) 
compared to participants below median ST/day, where no 
significant risk reduction was observed (HR 0.90, 95% 
CI 0.64–1.28) (P = 0.022 for interaction, Fig. 1). A simi-
lar pattern was observed for every 30-min/day increment 
in LPA (HR 0.84, 95% CI 0.73–0.96 vs HR 1.03, 95% CI 
0.86–1.24), although the interaction was not statistically sig-
nificant (P = 0.11).
Data are presented and means and standard deviations unless stated 
otherwise
Table 1  (continued)
Table 2  Associations of physical activity and sedentary time with incident stroke, myocardial infarction and all-cause mortality in 3343 men and 
women aged 70 who participated in the Healthy Ageing Initiative study during May 2012–October 2017
Model 1: adjusted for sex and accelerometer wear time
Model 2: adjusted for sex, accelerometer wear time, smoking status, marital status, level of education, disposable income
Model 3: adjusted for sex, accelerometer wear time, smoking status, marital status, level of education, disposable income, MI, stroke, angina 
pectoris, anti-hypertensives, anti-coagulants, statins
Model 4: adjusted for sex, accelerometer wear time, smoking status, marital status, level of education, disposable income, MI, stroke, angina 
pectoris, anti-hypertensives, anti-coagulants, statins, systolic blood pressure, visceral adipose tissue, fasting blood glucose, low-density lipopro-
tein cholesterol
CI confidence interval, HR hazard ratio, LPA light-intensity physical activity, MI myocardial infarction, MPA moderate-intensity physical activ-
ity, MVPA moderate-to-vigorous physical activity, ST sedentary time
a The small difference in the number of participants and events from model 1 through model 4 are caused by missing data for one or several of 
the covariates added in these models
Stroke, MI or all-cause 
mortality






Per 30-min increment 
of MVPA/day
Per 1-h increment of ST/day
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
 Model 1 3343 (124) 0.87 (0.80–0.95) 0.56 (0.43–0.73) 0.56 (0.43–0.74) 1.43 (1.22–1.68)
 Model 2 3334 (124) 0.88 (0.81–0.96) 0.62 (0.47–0.80) 0.61 (0.47–0.80) 1.38 (1.18–1.61)
 Model 3 3334 (124) 0.89 (0.82–0.96) 0.65 (0.50–0.85) 0.65 (0.50–0.84) 1.34 (1.15–1.56)
 Model 4 3280 (121) 0.89 (0.82–0.97) 0.64 (0.48–0.84) 0.64 (0.49–0.83) 1.33 (1.14–1.56)
Stroke or MI
 Model 1 3343 (74) 0.88 (0.78–0.98) 0.50 (0.35–0.73) 0.51 (0.35–0.73) 1.45 (1.18–1.78)
 Model 2 3333 (74) 0.88 (0.78–0.98) 0.55 (0.38–0.79) 0.55 (0.38–0.79) 1.41 (1.15–1.73)
 Model 3 3333 (74) 0.89 (0.79–0.99) 0.59 (0.41–0.84) 0.58 (0.41–0.83) 1.37 (1.12–1.68)
 Model 4 3279 (71) 0.88 (0.78–0.99) 0.59 (0.40–0.87) 0.59 (0.41–0.86) 1.38 (1.12–1.72)
All-cause mortality
 Model 1 3343 (57) 0.83 (0.74–0.94) 0.57 (0.39–0.85) 0.57 (0.39–0.84) 1.50 (1.21–1.86)
 Model 2 3333 (57) 0.85 (0.75–0.95) 0.62 (0.42–0.92) 0.62 (0.43–0.91) 1.43 (1.16–1.76)
 Model 3 3333 (57) 0.85 (0.76–0.95) 0.68 (0.47–0.97) 0.68 (0.47–0.96) 1.39 (1.13–1.70)
 Model 4 3280 (56) 0.87 (0.78–0.97) 0.61 (0.41–0.89) 0.60 (0.42–0.98) 1.36 (1.11–1.65)
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3.3  Sedentary Time and the Risk of CVD 
or Mortality
Every 1-h/day increment in ST was associated with 43% 
increased risk of CVD or mortality (HR 1.43, 95% CI 
1.22–1.68) when adjusted for sex and accelerometer wear 
time, and 33% increased risk in the finally adjusted model 
(HR 1.33, 95% CI 1.14–1.56, Table 2). As shown in the 
subgroup analyses (Fig. 3), the association between ST 
and the risk of CVD or mortality was modified by MPA 
(P = 0.034 for interaction). Specifically, while every 1-h/day 
increment in ST was associated with 29% increased risk of 
CVD or mortality among participants performing ≤ 15 min/
day of MPA (HR 1.29, 95% CI 1.01–1.65), the association 
was weakened for participants performing 16–29 min/day 
of MPA (HR 1.20, 95% CI 0.86–1.69) and further attenu-
ated for participants performing at least 30 min/day of MPA 
(HR 1.11, 95% CI 0.82–1.50). Furthermore, the association 
between ST and the risk of CVD or mortality was stronger 
in current smokers (HR 2.05, 95% CI 1.24–3.38) than in 
non-smokers (HR 1.26, 95% CI 1.07–1.49) (P = 0.014 for 
interaction, Fig. 3).
3.4  Sensitivity Analysis
After excluding all participants with a history of CVD and 
all participants with a follow-up time of 6 months or less, 
a total of 2779 participants and 97 events of CVD or mor-
tality (stroke 25; MI, 26; death, 46) were included in the 
sensitivity analysis. The results of this analysis were simi-
lar to the results in the main analysis. Specifically, neither 
the association between every 30-min/day of LPA and the 
risk of CVD or mortality (HR 0.88, 95% CI 0.80–0.98), nor 
the association between every 1-h/day of ST and the risk of 
CVD or mortality (HR 1.32, 95% CI 1.10–1.59) were altered 
after adjusting for sex, accelerometer wear time, smoking, 
socioeconomic factors, medications and cardiometabolic 
risk factors. The association between every 30-min/day of 
MPA and the risk of CVD or mortality was only slightly 
weakened (HR 0.70, 95% CI 0.52–0.96).
Fig. 1  Subgroup- and interaction analyses for the association between 
every 30-min/day increment in MPA and the composite endpoint of 
cardiovascular disease (stroke or myocardial infarction) or all-cause 
mortality. All HRs, CIs, and P values were derived from Cox regres-
sion models adjusted for sex and accelerometer wear time, as well as 
mutual adjustment for the other significant risk factors. CI confidence 
interval, HR hazard ratio, IR incidence rate, MPA moderate-intensity 
physical activity, PY person years
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Fig. 2  Subgroup- and interaction analyses for the association between 
every 30-min/day increment in LPA and the composite endpoint of 
cardiovascular disease (stroke or myocardial infarction) or all-cause 
mortality. All HRs, CIs, and P values were derived from Cox regres-
sion models adjusted for sex and accelerometer wear time, as well as 
mutual adjustment for the other significant risk factors. CI confidence 
interval, HR hazard ratio, IR incidence rate, LPA light-intensity physi-
cal activity, PY person years
Fig. 3  Subgroup- and interaction analyses for the association between 
every 1-h/day increment in ST and the composite endpoint of car-
diovascular disease (stroke or myocardial infarction) or all-cause 
mortality. All HRs, CIs, and P values were derived from Cox regres-
sion models adjusted for sex and accelerometer wear time, as well as 
mutual adjustment for the other significant risk factors. CI confidence 
interval, HR hazard ratio, IR incidence rate, PA physical activity, PY 
person years, ST sedentary time
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4  Discussion
In this prospective cohort study of 70-year-old individuals, 
we observed that greater amounts of objectively measured 
LPA and MPA were each associated with lower risk of 
stroke, MI or all-cause mortality, while greater amounts of 
ST were associated with increased risk of the outcomes. The 
associations were linear and independent of sex, accelerom-
eter wear time, smoking, socioeconomic status, pre-existing 
CVD, medications, and cardiometabolic risk factors. Con-
verted to 30 min/day increments, LPA was associated with 
11% lower risk of CVD or mortality, and MPA was associ-
ated with 36% lower risk of CVD or mortality. In contrast, 
every 1-h/day increment in ST was associated with 33% 
increased risk of CVD or mortality.
4.1  Outcomes
Earlier PA recommendations have primarily emphasized the 
importance of performing PA of at least moderate intensity; 
however, there is now an increasing interest in the poten-
tial benefits associated with LPA [16]. An emerging body 
of evidence indicate that LPA is associated with improved 
cardiometabolic markers, lower risk of CVD, and lower risk 
of premature death [23, 24, 33–36]. One of the key findings 
of the present study is that every 30-min/day increment in 
LPA was associated with 11% lower risk of CVD or mor-
tality, even after adjusting for a vast number of potential 
confounders and mediators. This is in contrast to previous 
studies which have reported no benefits [25, 26], although 
supported by two previous studies showing similar estimates 
of risk reduction [23, 24]. Whereas these studies included 
only women with a higher mean age, our findings add an 
important piece to the puzzle by suggesting that LPA may 
have important benefits in both older men and women and of 
slightly younger age. Given that older people spend a major-
ity of their awake time performing LPA and being sedentary 
[19, 37], these findings may have important implications 
from a public health perspective.
However, the results of the present study suggest that the 
largest estimated relative risk reduction is achieved through 
MPA. Converted to a 30-min/day increment, we found that 
MPA was associated with 36% lower risk of CVD or mor-
tality, which extends the findings from previous studies [23, 
26]. Of interest is that MPA showed a stronger association 
with CVD or mortality than LPA did, which with the lim-
itation of being an observational study may indicate that 
higher intensity PA could be more beneficial with respect 
to prevention of CVD in the older individual. In light of 
this, it is of interest that in two randomized controlled trials 
conducted in similar populations, we found that 10 weeks of 
high-intensity exercise had positive effects on cardiovascular 
risk factors in 70-year-old men and women [38–40].
We also analyzed the associations of LPA and MPA in 
subgroups stratified based on amount of ST. Because the 
stratification resulted in smaller sample sizes, these are 
exploratory and preliminary findings which should be cau-
tiously interpreted, and which require replication in larger 
studies before conclusions can be drawn. Nevertheless, they 
did reveal some interesting findings. Greater LPA and MPA 
were each associated with lower risk of CVD or mortality in 
older adults who were sedentary for around 9 h/day or more, 
but not in those with less ST. In this sense, it should be noted 
that the more sedentary half of our population is likely most 
representative of the general older individual [41, 42], and 
the findings could be interpreted as a reinforcement that as 
people age and become more sedentary, the importance of 
PA increases [41, 42].
The impact of sedentary behavior has gained increased 
attention during recent years and may be particularly impor-
tant to study in older populations given the demographic 
shift towards more older people in our society [6]. In the 
present study, we observed a 33% increased risk of CVD 
or mortality for every 1-h/day increment in ST, which is 
considerably higher than the 12% risk estimate in a recent 
study in older women [43]. However, a perhaps even more 
important and interesting finding was that increased levels 
of MPA appeared to attenuate some of the risks associated 
with sedentary behavior. Already at a cut-point of 15 min/
day of MPA, the association of ST with CVD or mortality 
was weaker, and the association was further weakened in 
participants with at least 30 min/day of MPA. These find-
ings stand in contrast to a previous study on older men [44], 
which showed that adhering to the PA recommendations is 
not sufficient to attenuate the association of ST with mor-
tality. However, the phenomenon has some support from 
previous meta-analyses which showed that 60–75 min of 
self-reported MPA/day diminishes the risk of mortality in 
sedentary individuals [45, 46]. However, as mentioned in the 
previous paragraph, the results of these subgroup analyses 
are preliminary and need to be replicated in larger studies. 
Because ST constitutes a large proportion of older peoples’ 
daily activity, it would have important implications for clini-
cal practice if it can be established that MPA can attenuate 
some of the increased risks of CVD or mortality pertaining 
to prolonged ST [21, 22].
4.2  Limitations and Strengths
There are some methodological aspects that need to be 
addressed. First, the present study had an observational design, 
meaning that causality cannot be established. There were 
also relatively few outcome events during follow-up, which 
may have influenced the statistical power of the analyses. In 
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particular, this could be the case for the stratified analyses, 
and therefore, these are rather exploratory findings which 
require further confirmation. Still, there was sufficient power 
for the performed main analyses of PA and ST in relation to the 
outcomes. Furthermore, when studying PA in older adults in 
relation to incident disease, there is a risk of bias from reverse 
causation, so that the low PA at baseline in some participants 
may be due to early onset, or previous history of disease, as 
opposed to volitional inactivity, creating the association of 
PA with CVD. In an attempt to decrease this risk of bias, we 
excluded all participants with a history of CVD and with a 
short follow-up in a sensitivity analysis. As shown, the associa-
tions were only marginally altered. However, it is possible that 
some residual confounding still remains, as a recent paper sug-
gested that the first 5 years of follow-up should be excluded to 
minimize reverse-causality bias [47]. Another methodological 
aspect to consider is the extent to which a single PA assess-
ment represents “true” patterns of activity. A previous study 
showed that a 7-day assessment provided reliable estimates of 
PA and ST in older women over a period of 2–3 years [48]. It 
should, however, be noted that biased estimates of PA among 
the participants would likely attenuate all associations towards 
zero. Next, while there is no consensus on cut-points for inten-
sity thresholds, the cut-points used in the present study are 
the most frequently utilized ones in studies on community-
dwelling older adults, with the advantage of facilitating inter-
study comparisons [49]. However, it should be noted that these 
were originally validated in younger adults [28], which would 
translate into higher relative intensities in the present cohort 
of 70-year-olds. Yet, the results showed that by using these 
cut-points, both LPA and MPA was associated with lower risk 
of CVD or mortality in our cohort of older men and women. 
Interestingly, similar associations were found in a recent meta-
analysis on both middle-aged and older adults using same cut-
points for intensity classification [33].
The present study also has several strengths. First, the use 
of accelerometers to objectively measure PA is an important 
strength which allows for accurate quantification of seden-
tary behavior and different intensities of PA as opposed to 
self-report measures [19, 20, 50]. For instance, in a previous 
study based on the same cohort, self-reported PA was more 
than twice that of accelerometer-derived measures of PA 
[51]. There was also a very high adherence to wearing the 
accelerometer, as more than 92% of the participants had suf-
ficient wear time. Moreover, the study cohort which included 
over 3300 consecutive participants, with an equal distribu-
tion between women and men, was based on an ongoing 
population-based study with no exclusion criteria. There is, 
therefore, good potential for the findings to be generalized to 
other cohorts of community-dwelling older adults. We also 
adjusted for an extensive number of potential confounders 
and mediators thought to be in the causal pathway between 
PA and CVD, including smoking, socioeconomic factors, 
medical history, medications, and cardiometabolic risk fac-
tors. Altogether, these above-mentioned factors increase 
both the internal and external validity of the results.
5  Conclusion
To summarize, this prospective study of more than 3300, 
70-year-old men and women shows that objectively meas-
ured LPA and MPA are each associated with lower risk of 
stroke, MI or all-cause mortality, while ST is associated 
with increased risk of stroke, MI or all-cause mortality. 
In light of the rapid population ageing and persistent high 
burden of CVD in older people, our results may influence 
and support environmental actions and interventions aim-
ing to reduce the risk of CVD and premature death in older 
adults by emphasizing the importance of promoting PA of 
all intensities and reducing ST. Finally, our findings can 
further be translated into three concrete messages that are 
easily communicated to the public: first, “regardless of 
intensity, the more you move and the less you sit, the bet-
ter”. Second, “if you are able, aim to perform also MPA, 
such as brisk walking, as this may have even larger ben-
efits”. Third, “by increasing the amount of MPA you may 
potentially mitigate some of the increased risks pertaining 
to sedentary behavior”.
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